MEDTRONIC PLC 2024-2025 Proxy Voting Records

Description as filed by funds: Electing, by separate resolutions, the ten director nominees named in the proxy statement to hold office until the 2025 Annual General Meeting of Medtronic plc (the "Company"): Craig Arnold

MEDTRONIC PLC’s own tally for this item (“Elect Director: Craig Arnold”): 952,980,300 for, 45,113,878 against, per its Form 8-K filed October 21, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The shareholders elected each of the ten nominees to the Board of Directors, to hold office until the 2025 Annual General Meeting of the Company and until his or her successor is elected, as follows:”
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 223 asset managers below reported 431,561,692 for, 623,738 against, 193,206 abstained.

Showing the 25 largest of 223 asset managers. See all 223 in the interactive database.

Description as filed by funds: Electing, by separate resolutions, the ten director nominees named in the proxy statement to hold office until the 2025 Annual General Meeting of Medtronic plc (the "Company"): Scott C. Donnelly

MEDTRONIC PLC’s own tally for this item (“Elect Director: Scott C. Donnelly”): 964,223,711 for, 34,734,436 against, per its Form 8-K filed October 21, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The shareholders elected each of the ten nominees to the Board of Directors, to hold office until the 2025 Annual General Meeting of the Company and until his or her successor is elected, as follows:”
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 223 asset managers below reported 429,165,508 for, 3,019,968 against, 193,161 abstained.

Showing the 25 largest of 223 asset managers. See all 223 in the interactive database.

Description as filed by funds: Electing, by separate resolutions, the ten director nominees named in the proxy statement to hold office until the 2025 Annual General Meeting of Medtronic plc (the "Company"): Lidia L. Fonseca

MEDTRONIC PLC’s own tally for this item (“Elect Director: Lidia L. Fonseca”): 983,895,789 for, 15,081,990 against, per its Form 8-K filed October 21, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The shareholders elected each of the ten nominees to the Board of Directors, to hold office until the 2025 Annual General Meeting of the Company and until his or her successor is elected, as follows:”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 223 asset managers below reported 432,104,353 for, 80,224 against, 194,059 abstained.

Showing the 25 largest of 223 asset managers. See all 223 in the interactive database.

Description as filed by funds: Electing, by separate resolutions, the ten director nominees named in the proxy statement to hold office until the 2025 Annual General Meeting of Medtronic plc (the "Company"): Andrea J. Goldsmith, Ph.D.

MEDTRONIC PLC’s own tally for this item (“Elect Director: Andrea J. Goldsmith, Ph.D.”): 994,796,259 for, 4,135,950 against, per its Form 8-K filed October 21, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The shareholders elected each of the ten nominees to the Board of Directors, to hold office until the 2025 Annual General Meeting of the Company and until his or her successor is elected, as follows:”
Support: 99.5% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 223 asset managers below reported 432,142,582 for, 16,904 against, 219,151 abstained.

Showing the 25 largest of 223 asset managers. See all 223 in the interactive database.

Description as filed by funds: Electing, by separate resolutions, the ten director nominees named in the proxy statement to hold office until the 2025 Annual General Meeting of Medtronic plc (the "Company"): Randall J. Hogan, III

MEDTRONIC PLC’s own tally for this item (“Elect Director: Randall J. Hogan, III”): 992,550,812 for, 6,398,816 against, per its Form 8-K filed October 21, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The shareholders elected each of the ten nominees to the Board of Directors, to hold office until the 2025 Annual General Meeting of the Company and until his or her successor is elected, as follows:”
Support: 99.3% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 223 asset managers below reported 432,171,563 for, 13,912 against, 193,161 abstained.

Showing the 25 largest of 223 asset managers. See all 223 in the interactive database.

Description as filed by funds: Electing, by separate resolutions, the ten director nominees named in the proxy statement to hold office until the 2025 Annual General Meeting of Medtronic plc (the "Company"): Gregory P. Lewis

MEDTRONIC PLC’s own tally for this item (“Elect Director: Gregory P. Lewis”): 985,323,082 for, 13,626,512 against, per its Form 8-K filed October 21, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The shareholders elected each of the ten nominees to the Board of Directors, to hold office until the 2025 Annual General Meeting of the Company and until his or her successor is elected, as follows:”
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 223 asset managers below reported 432,150,545 for, 135,880 against, 194,061 abstained.

Showing the 25 largest of 223 asset managers. See all 223 in the interactive database.

Description as filed by funds: Electing, by separate resolutions, the ten director nominees named in the proxy statement to hold office until the 2025 Annual General Meeting of Medtronic plc (the "Company"): Kevin E. Lofton

MEDTRONIC PLC’s own tally for this item (“Elect Director: Kevin E. Lofton”): 990,923,667 for, 8,030,691 against, per its Form 8-K filed October 21, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The shareholders elected each of the ten nominees to the Board of Directors, to hold office until the 2025 Annual General Meeting of the Company and until his or her successor is elected, as follows:”
Support: 99.1% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 223 asset managers below reported 432,142,005 for, 43,470 against, 193,161 abstained.

Showing the 25 largest of 223 asset managers. See all 223 in the interactive database.

Description as filed by funds: Electing, by separate resolutions, the ten director nominees named in the proxy statement to hold office until the 2025 Annual General Meeting of Medtronic plc (the "Company"): Geoffrey S. Martha

MEDTRONIC PLC’s own tally for this item (“Elect Director: Geoffrey S. Martha”): 943,041,061 for, 53,318,321 against, per its Form 8-K filed October 21, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The shareholders elected each of the ten nominees to the Board of Directors, to hold office until the 2025 Annual General Meeting of the Company and until his or her successor is elected, as follows:”
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 223 asset managers below reported 431,864,651 for, 319,916 against, 194,069 abstained.

Showing the 25 largest of 223 asset managers. See all 223 in the interactive database.

Description as filed by funds: Electing, by separate resolutions, the ten director nominees named in the proxy statement to hold office until the 2025 Annual General Meeting of Medtronic plc (the "Company"): Elizabeth G. Nabel, M.D.

MEDTRONIC PLC’s own tally for this item (“Elect Director: Elizabeth G. Nabel, M.D.”): 966,622,750 for, 32,366,858 against, per its Form 8-K filed October 21, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The shareholders elected each of the ten nominees to the Board of Directors, to hold office until the 2025 Annual General Meeting of the Company and until his or her successor is elected, as follows:”
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 223 asset managers below reported 430,391,732 for, 1,793,746 against, 193,159 abstained.

Showing the 25 largest of 223 asset managers. See all 223 in the interactive database.

Description as filed by funds: Electing, by separate resolutions, the ten director nominees named in the proxy statement to hold office until the 2025 Annual General Meeting of Medtronic plc (the "Company"): Kendall J. Powell

MEDTRONIC PLC’s own tally for this item (“Elect Director: Kendall J. Powell”): 906,406,435 for, 91,375,803 against, per its Form 8-K filed October 21, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The shareholders elected each of the ten nominees to the Board of Directors, to hold office until the 2025 Annual General Meeting of the Company and until his or her successor is elected, as follows:”
Support: 91% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 223 asset managers below reported 422,802,083 for, 9,485,180 against, 193,223 abstained.

Showing the 25 largest of 223 asset managers. See all 223 in the interactive database.

Description as filed by funds: Authorizing the Company and any subsidiary of the Company to make overseas market purchases of Medtronic ordinary shares.

MEDTRONIC PLC’s own tally for this item (“6. Authorization of the Company and any subsidiary of the Company to make overseas market purchases of Medtronic ordinary shares”): 1,086,792,639 for, 27,683,267 against — passed, per its Form 8-K filed October 21, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The shareholders approved authorization of the Company and any subsidiary of the Company to make overseas market purchases of Medtronic ordinary shares.”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 228 asset managers below reported 432,427,275 for, 2,863 against, 1,051 abstained.

Showing the 25 largest of 228 asset managers. See all 228 in the interactive database.

Description as filed by funds: Renewing the Board of Directors' authority to opt out of pre-emption rights under Irish law; and

MEDTRONIC PLC’s own tally for this item (“5. Renewal of the Board's authority to opt out of pre-emption rights”): 1,042,690,218 for, 68,667,595 against — passed, per its Form 8-K filed October 21, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The shareholders approved renewal of the Board's authority to opt out of pre-emption rights.”
Support: 94% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Also reported under other wordings, matched to the same row of MEDTRONIC PLC’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Eliminate Pre-Emptive Rights” (2 managers, 2,070 for).

The 225 asset managers below reported 431,457,141 for, 970,791 against, 1,150 abstained.

Showing the 25 largest of 225 asset managers. See all 225 in the interactive database.

Description as filed by funds: Renewing the Board of Directors' authority to issue shares under Irish law;

MEDTRONIC PLC’s own tally for this item (“4. Renewal of the Board's authority to issue shares”): 1,094,709,167 for, 17,315,138 against — passed, per its Form 8-K filed October 21, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The shareholders approved renewal of the Board's authority to issue shares.”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 221 asset managers below reported 431,100,613 for, 455,223 against, 1,131 abstained.

Showing the 25 largest of 221 asset managers. See all 221 in the interactive database.

Description as filed by funds: Approving, on an advisory basis, the Company's executive compensation.

MEDTRONIC PLC’s own tally for this item (“3. On a non-binding advisory basis, the compensation awarded to the Company's named executive officers”): 924,541,222 for, 70,301,925 against — passed, per its Form 8-K filed October 21, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The shareholders approved, on a non-binding advisory basis, the compensation awarded to the Company's named executive officers.”
Support: 93% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Also reported under other wordings, matched to the same row of MEDTRONIC PLC’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “COMPENSATION” (2 managers, 1,013 for); “Say on Pay” (2 managers, 39,442 for).

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports, all 212 managers: 431,321,907 for, 653,850 against, 189,198 abstained. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports, all 1,181 managers: 567,667,573 for, 41,360,061 against, 200 withheld, 58,538 abstained, 73,777 not voted, 5,175 unknown. Showing the 25 largest; see all in the interactive database.

Description as filed by funds: Ratifying, in a non-binding vote, the appointment of PricewaterhouseCoopers LLP as the Company's independent auditor for fiscal year 2025 and authorizing, in a binding vote, the Board of Directors, acting through the Audit Committee, to set the auditor's remuneration;

MEDTRONIC PLC’s own tally for this item (“2. In a non-binding vote, the appointment of PricewaterhouseCoopers LLP as Medtronic's independent auditor for fiscal year 2025 and to authorize, in a binding vote, the Board of Directors, acting through the Audit Commit”): 1,008,653,733 for, 107,729,791 against — passed, per its Form 8-K filed October 21, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The shareholders ratified, in a non-binding vote, the appointment of PricewaterhouseCoopers LLP as Medtronic's independent auditor for fiscal year 2025 and to authorize, in a binding vote, the Board of Directors, acting through the Audit Committee, to set the auditor's remuneration.”
Support: 90% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 227 asset managers below reported 423,523,580 for, 8,748,438 against, 210,577 abstained.

Showing the 25 largest of 227 asset managers. See all 227 in the interactive database.